OraSure Technologies Inc (OSUR)
5.27
+0.02
(+0.38%)
USD |
NASDAQ |
Apr 19, 10:21
OraSure Technologies Cash from Investing (TTM): 66.15M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 66.15M |
September 30, 2023 | 61.17M |
June 30, 2023 | 61.52M |
March 31, 2023 | 32.04M |
December 31, 2022 | 21.08M |
September 30, 2022 | -10.76M |
June 30, 2022 | -18.14M |
March 31, 2022 | -38.10M |
December 31, 2021 | -5.501M |
September 30, 2021 | -9.337M |
June 30, 2021 | -16.80M |
March 31, 2021 | -5.511M |
December 31, 2020 | -14.03M |
September 30, 2020 | -13.81M |
June 30, 2020 | 11.77M |
March 31, 2020 | 10.56M |
December 31, 2019 | -19.80M |
September 30, 2019 | -9.835M |
June 30, 2019 | -23.38M |
March 31, 2019 | -19.87M |
December 31, 2018 | -17.43M |
September 30, 2018 | -20.82M |
June 30, 2018 | -63.61M |
March 31, 2018 | -101.73M |
December 31, 2017 | -96.35M |
Date | Value |
---|---|
September 30, 2017 | -97.58M |
June 30, 2017 | -50.55M |
March 31, 2017 | -14.86M |
December 31, 2016 | -8.065M |
September 30, 2016 | -5.371M |
June 30, 2016 | -5.328M |
March 31, 2016 | -8.90M |
December 31, 2015 | -6.705M |
September 30, 2015 | -5.498M |
June 30, 2015 | -5.668M |
March 31, 2015 | -6.731M |
December 31, 2014 | -7.98M |
September 30, 2014 | -8.094M |
June 30, 2014 | -7.788M |
March 31, 2014 | -2.629M |
December 31, 2013 | -2.462M |
September 30, 2013 | -2.313M |
June 30, 2013 | -2.381M |
March 31, 2013 | -2.193M |
December 31, 2012 | -2.019M |
September 30, 2012 | -1.857M |
June 30, 2012 | -51.79M |
March 31, 2012 | -49.76M |
December 31, 2011 | -50.34M |
September 30, 2011 | -51.25M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-38.10M
Minimum
Mar 2022
66.15M
Maximum
Dec 2023
4.174M
Average
-9.337M
Median
Sep 2021
Cash from Investing (TTM) Benchmarks
Abbott Laboratories | -3.133B |
Integra Lifesciences Holdings Corp | -94.18M |
Insulet Corp | -119.40M |
Perspective Therapeutics Inc | 24.37M |
Xtant Medical Holdings Inc | -24.78M |